394 related articles for article (PubMed ID: 34000465)
1. Mild hyperthermia promotes immune checkpoint blockade-based immunotherapy against metastatic pancreatic cancer using size-adjustable nanoparticles.
Yu Q; Tang X; Zhao W; Qiu Y; He J; Wan D; Li J; Wang X; He X; Liu Y; Li M; Zhang Z; He Q
Acta Biomater; 2021 Oct; 133():244-256. PubMed ID: 34000465
[TBL] [Abstract][Full Text] [Related]
2. Targeting cancer-associated fibroblasts by dual-responsive lipid-albumin nanoparticles to enhance drug perfusion for pancreatic tumor therapy.
Yu Q; Qiu Y; Li J; Tang X; Wang X; Cun X; Xu S; Liu Y; Li M; Zhang Z; He Q
J Control Release; 2020 May; 321():564-575. PubMed ID: 32112854
[TBL] [Abstract][Full Text] [Related]
3. Hollow Cu2MoS4 nanoparticles loaded with immune checkpoint inhibitors reshape the tumor microenvironment to enhance immunotherapy for pancreatic cancer.
Yao Z; Qi C; Zhang F; Yao H; Wang C; Cao X; Zhao C; Wang Z; Qi M; Yao C; Wang X; Xia H
Acta Biomater; 2024 Jan; 173():365-377. PubMed ID: 37890815
[TBL] [Abstract][Full Text] [Related]
4. Multifunctional nanoparticles precisely reprogram the tumor microenvironment and potentiate antitumor immunotherapy after near-infrared-II light-mediated photothermal therapy.
Ge Y; Zhang J; Jin K; Ye Z; Wang W; Zhou Z; Ye J
Acta Biomater; 2023 Sep; 167():551-563. PubMed ID: 37302731
[TBL] [Abstract][Full Text] [Related]
5. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
6. Synergistic enhancement of immunological responses triggered by hyperthermia sensitive Pt NPs
Yu J; Liu S; Wang Y; He X; Zhang Q; Qi Y; Zhou D; Xie Z; Li X; Huang Y
Bioact Mater; 2022 Jan; 7():389-400. PubMed ID: 34466740
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-mediated blockade of CXCL12/CXCR4 signaling enhances glioblastoma immunotherapy: Monitoring early responses with MRI radiomics.
Wei R; Li J; Lin W; Pang X; Yang H; Lai S; Wei X; Jiang X; Yuan Y; Yang R
Acta Biomater; 2024 Mar; 177():414-430. PubMed ID: 38360292
[TBL] [Abstract][Full Text] [Related]
8. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
9. A nanodrug simultaneously inhibits pancreatic stellate cell activation and regulatory T cell infiltration to promote the immunotherapy of pancreatic cancer.
Wang R; Hong K; Zhang Q; Cao J; Huang T; Xiao Z; Wang Y; Shuai X
Acta Biomater; 2023 Oct; 169():451-463. PubMed ID: 37572982
[TBL] [Abstract][Full Text] [Related]
10. Dual-Stage Irradiation of Size-Switchable Albumin Nanocluster for Cascaded Tumor Enhanced Penetration and Photothermal Therapy.
He P; Lei Q; Yang B; Shang T; Shi J; Ouyang Q; Wang W; Xue L; Kong F; Li Z; Huang J; Liu L; Guo J; Brinker CJ; Liu K; Zhu W
ACS Nano; 2022 Sep; 16(9):13919-13932. PubMed ID: 36082976
[TBL] [Abstract][Full Text] [Related]
11. Surface-Functionalized Modified Copper Sulfide Nanoparticles Enhance Checkpoint Blockade Tumor Immunotherapy by Photothermal Therapy and Antigen Capturing.
Wang R; He Z; Cai P; Zhao Y; Gao L; Yang W; Zhao Y; Gao X; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13964-13972. PubMed ID: 30912920
[TBL] [Abstract][Full Text] [Related]
12. Thermal-sensitive lipid nanoparticles potentiate anti-PD therapy through enhancing drug penetration and T lymphocytes infiltration in metastatic tumor.
Tan YN; Li YP; Huang JD; Luo M; Li SS; Lee AW; Hu FQ; Guan XY
Cancer Lett; 2021 Dec; 522():238-254. PubMed ID: 34571084
[TBL] [Abstract][Full Text] [Related]
13. Cancer-cell-biomimetic nanoparticles systemically eliminate hypoxia tumors by synergistic chemotherapy and checkpoint blockade immunotherapy.
Yao Y; Chen H; Tan N
Acta Pharm Sin B; 2022 Apr; 12(4):2103-2119. PubMed ID: 35847496
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive Liposomal Codelivery of HSA-Paclitaxel and HSA-Ellagic Acid Complexes for Enhanced Drug Perfusion and Efficacy Against Pancreatic Cancer.
Wei Y; Wang Y; Xia D; Guo S; Wang F; Zhang X; Gan Y
ACS Appl Mater Interfaces; 2017 Aug; 9(30):25138-25151. PubMed ID: 28696100
[TBL] [Abstract][Full Text] [Related]
15. Self-promoted Albumin-Based Nanoparticles for Combination Therapy against Metastatic Breast Cancer via a Hyperthermia-Induced "Platelet Bridge".
Zhao W; Li T; Long Y; Guo R; Sheng Q; Lu Z; Li M; Li J; Zang S; Zhang Z; He Q
ACS Appl Mater Interfaces; 2021 Jun; 13(22):25701-25714. PubMed ID: 34041901
[TBL] [Abstract][Full Text] [Related]
16. Ferrimagnetic Vortex Nanoring-Mediated Mild Magnetic Hyperthermia Imparts Potent Immunological Effect for Treating Cancer Metastasis.
Liu X; Zheng J; Sun W; Zhao X; Li Y; Gong N; Wang Y; Ma X; Zhang T; Zhao LY; Hou Y; Wu Z; Du Y; Fan H; Tian J; Liang XJ
ACS Nano; 2019 Aug; 13(8):8811-8825. PubMed ID: 31328922
[TBL] [Abstract][Full Text] [Related]
17. Atovaquone-HSA nano-drugs enhance the efficacy of PD-1 blockade immunotherapy by alleviating hypoxic tumor microenvironment.
Wang S; Zhou X; Zeng Z; Sui M; Chen L; Feng C; Huang C; Yang Q; Ji M; Hou P
J Nanobiotechnology; 2021 Oct; 19(1):302. PubMed ID: 34600560
[TBL] [Abstract][Full Text] [Related]
18. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
19. Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors.
Yang X; Gao M; Xu R; Tao Y; Luo W; Wang B; Zhong W; He L; He Y
Front Immunol; 2022; 13():969447. PubMed ID: 36032103
[TBL] [Abstract][Full Text] [Related]
20. Advances in immunotherapy for pancreatic ductal adenocarcinoma.
Miyazawa M; Katsuda M; Kawai M; Hirono S; Okada KI; Kitahata Y; Yamaue H
J Hepatobiliary Pancreat Sci; 2021 May; 28(5):419-430. PubMed ID: 33742512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]